Email Newsletters
Subscribe

Biostage

Biostage rebrands by reclaiming former name to reflect regenerative technology

Holliston biotech firm Biostage has rebranded back to its former name, Harvard Apparatus Regenerative Technology.

Biostage secures $6M to advance clinical trials

Biostage, a cell-therapy biotech company based in Holliston, has received $6 million in commitments from investors to accelerate its clinical development program.

Biostage names industry veteran as new CFO

Holliston bioscience company Biostage has hired a public financing and Nasdaq listing expert as its new CFO. 

Biostage’s new patent expands treatment into lungs

Holliston biotechnology company Biostage Inc. has secured a patent to allow the company known for its esophageal cancer treatment research to pursue treatments for lung cancer.
- Advertisement -

Biostage yearly losses hit $8M in 2021

Holliston biotechnology company Biostage Inc. saw its net losses for the year climb by $3.1 million to approximately $8 million as a result of ongoing wrongful death litigation.

Biostage cash on-hand falls to $500K

Holliston biotechnology company Biostage Inc. reported it has $500,000 in operating cash on hand, enough to carry it into the third quarter.

Biostage cuts annual losses by $3.4M

Holliston biotechnology company Biostage Inc. cut its yearly losses by $3.4 million through reductions in research & development and administrative expenses.

Biostage cuts third quarter losses

Holliston biotechnology company Biostage, Inc. announced last week it had cut its third quarter losses through reductions in research and development and administrative expenses.
- Advertisement -

Biostage cash reserves drop to $1M as R&D costs climb

The losses rose in the third quarter for Holliston biotech startup Biostage as the company continues to push towards clinical trials of its esophageal implants.

Biostage applies to FDA for esophageal implant

Biostage has applied to the U.S. Food and Drug Administration for a new esophageal implant, the Holliston bioengineering firm announced Wednesday.
12Page 1 of 2
Get our email newsletters

Stay up-to-date on the companies, people and issues that impact businesses in Central Massachusetts.

Sign Up Now
ADVERTISEMENT

Latest Stories

More Business News
ADVERTISEMENT

Thought Leadership

More Thought Leadership

Career Opportunities

More Jobs | Submit a Job

Upcoming Events

View Calendar
More Events | Submit an Event
Business news, insights, and data on the companies, people, and trends shaping Central Massachusetts, and beyond.

About

About Us
Advertising
Contact / Staff
Careers
Journalism Principles

Subscribe

Subscribe to WBJ
Premium Data Subscription
Manage Your Account
Frequently Asked Questions
WBJ Editions Archives

Follow WBJ

Copyright © 2025 New England Business Media. All Rights Reserved.

Get our email newsletter

Stay up-to-date on the companies, people and issues that impact businesses in Central Massachusetts.

Close the CTA